Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Galectin 3 industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Galectin Therapeutics Inc
Angion Biomedica Corp
GlycoMimetics Inc
Bristol-Myers Squibb Company
MandalMed Inc
By Type:
ANG-4021
GRMD-03
GAL-300
KTI
Others
By Application:
Metastatic Melanoma
Others
Portal Hypertension
Liver Cirrhosis
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Galectin 3 Market Overview 2018-2029
-
1.1 China Galectin 3 Industry Development Overview
-
1.2 China Galectin 3 Industry Development History
-
1.3 China Galectin 3 Industry Market Size (2018-2029)
-
1.4 China Galectin 3 Market Analysis by Type from Production Side
-
1.4.1 China Galectin 3 Production Volume, Production Value and Growth Rate of ANG-4021 (2018-2029)
-
1.4.2 China Galectin 3 Production Volume, Production Value and Growth Rate of GRMD-03 (2018-2029)
-
1.4.3 China Galectin 3 Production Volume, Production Value and Growth Rate of GAL-300 (2018-2029)
-
1.4.4 China Galectin 3 Production Volume, Production Value and Growth Rate of KTI (2018-2029)
-
1.4.5 China Galectin 3 Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
1.5 China Galectin 3 Market Analysis by Application from Consumption End
-
1.5.1 China Galectin 3 Sales Volume, Sales Value and Growth Rate of Metastatic Melanoma (2018-2029)
-
1.5.2 China Galectin 3 Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
1.5.3 China Galectin 3 Sales Volume, Sales Value and Growth Rate of Portal Hypertension (2018-2029)
-
1.5.4 China Galectin 3 Sales Volume, Sales Value and Growth Rate of Liver Cirrhosis (2018-2029)
-
1.6 China Galectin 3 Market Analysis by Region
-
1.6.1 North China Galectin 3 Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Galectin 3 Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Galectin 3 Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Galectin 3 Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Galectin 3 Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Galectin 3 Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Galectin 3 Market Size and Growth Rate from 2018-2029
Chapter 2 China Galectin 3 Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Galectin 3 Market Status and Competition at home and abroad in 2023
-
2.2.2 China Galectin 3 Market Status and Competition Analysis in 2023
-
2.2.3 China Galectin 3 Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Galectin 3 Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Galectin 3 Industry Development
Chapter 3 Galectin 3Industry Chain Analysis
-
3.1 Galectin 3 Industry Chain
-
3.2 Galectin 3 Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Galectin 3 Market
-
3.3 Galectin 3 Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Galectin 3 Market
Chapter 4 China Galectin 3 Market, by Type
-
4.1 China Galectin 3 Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Galectin 3 Total Production Volume and Growth Rate from Production Side
-
4.5 China Galectin 3 Production Volume and Growth Rate, by Type
-
4.5.1 China Galectin 3 Production Volume and Growth Rate of ANG-4021
-
4.5.2 China Galectin 3 Production Volume and Growth Rate of GRMD-03
-
4.5.3 China Galectin 3 Production Volume and Growth Rate of GAL-300
-
4.5.4 China Galectin 3 Production Volume and Growth Rate of KTI
-
4.5.5 China Galectin 3 Production Volume and Growth Rate of Others
Chapter 5 China Galectin 3 Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Galectin 3 Total Market Size and Growth Rate from Consumption End
-
5.5 China Galectin 3 Market Size and Growth Rate, by Application
-
5.5.1 China Galectin 3 Market Size and Growth Rate of Metastatic Melanoma
-
5.5.2 China Galectin 3 Market Size and Growth Rate of Others
-
5.5.3 China Galectin 3 Market Size and Growth Rate of Portal Hypertension
-
5.5.4 China Galectin 3 Market Size and Growth Rate of Liver Cirrhosis
Chapter 6 China Galectin 3 Market, by Region
-
6.1 China Galectin 3 Production Volume and Production Value, by Region
-
6.2 China Galectin 3 Sales Volume and Sales Value, by Region
Chapter 7 North China Galectin 3 Market Analysis
-
7.1 North China Galectin 3 Market, by Type
-
7.2 North China Galectin 3 Market, by Application
Chapter 8 Central China Galectin 3 Market Analysis
-
8.1 Central China Galectin 3 Market, by Type
-
8.2 Central China Galectin 3 Market, by Application
Chapter 9 South China Galectin 3 Market Analysis
-
9.1 South China Galectin 3 Market, by Type
-
9.2 South China Galectin 3 Market, by Application
Chapter 10 East China Galectin 3 Market Analysis
-
10.1 East China Galectin 3 Market, by Type
-
10.2 East China Galectin 3 Market, by Application
Chapter 11 Northeast China Galectin 3 Market Analysis
-
11.1 Northeast China Galectin 3 Market, by Type
-
11.2 Northeast China Galectin 3 Market, by Application
Chapter 12 Southwest China Galectin 3 Market Analysis
-
12.1 Southwest China Galectin 3 Market, by Type
-
12.2 Southwest China Galectin 3 Market, by Application
Chapter 13 Northwest China Galectin 3 Market Analysis
-
13.1 Northwest China Galectin 3 Market, by Type
-
13.2 Northwest China Galectin 3 Market, by Application
Chapter 14 Company Profiles
-
14.1 Galectin Therapeutics Inc
-
14.1.1 Galectin Therapeutics Inc Company Profile
-
14.1.2 Galectin Therapeutics Inc Galectin 3 Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Angion Biomedica Corp
-
14.2.1 Angion Biomedica Corp Company Profile
-
14.2.2 Angion Biomedica Corp Galectin 3 Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 GlycoMimetics Inc
-
14.3.1 GlycoMimetics Inc Company Profile
-
14.3.2 GlycoMimetics Inc Galectin 3 Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Bristol-Myers Squibb Company
-
14.4.1 Bristol-Myers Squibb Company Company Profile
-
14.4.2 Bristol-Myers Squibb Company Galectin 3 Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 MandalMed Inc
-
14.5.1 MandalMed Inc Company Profile
-
14.5.2 MandalMed Inc Galectin 3 Market Performance
-
14.5.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Galectin 3 Industry Research Conclusions
-
15.2 Galectin 3 Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Galectin 3 Industry Market Size (2018-2029)
-
Figure China Galectin 3 Production Volume, Production Value and Growth Rate of ANG-4021 (2018-2029)
-
Figure China Galectin 3 Production Volume, Production Value and Growth Rate of GRMD-03 (2018-2029)
-
Figure China Galectin 3 Production Volume, Production Value and Growth Rate of GAL-300 (2018-2029)
-
Figure China Galectin 3 Production Volume, Production Value and Growth Rate of KTI (2018-2029)
-
Figure China Galectin 3 Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
Figure China Galectin 3 Sales Volume, Sales Value and Growth Rate of Metastatic Melanoma (2018-2029)
-
Figure China Galectin 3 Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
Figure China Galectin 3 Sales Volume, Sales Value and Growth Rate of Portal Hypertension (2018-2029)
-
Figure China Galectin 3 Sales Volume, Sales Value and Growth Rate of Liver Cirrhosis (2018-2029)
-
Figure North China Galectin 3 Market Size and Growth Rate from 2018-2029
-
Figure Central China Galectin 3 Market Size and Growth Rate from 2018-2029
-
Figure South China Galectin 3 Market Size and Growth Rate from 2018-2029
-
Figure East China Galectin 3 Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Galectin 3 Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Galectin 3 Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Galectin 3 Market Size and Growth Rate from 2018-2029
-
Figure Galectin 3 Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Galectin 3 Market Share by Type in 2018
-
Figure China Galectin 3 Market Share by Type in 2023
-
Figure China Galectin 3 Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Galectin 3 Production Volume and Growth Rate of ANG-4021 (2018-2023)
-
Figure China Galectin 3 Production Volume and Growth Rate of GRMD-03 (2018-2023)
-
Figure China Galectin 3 Production Volume and Growth Rate of GAL-300 (2018-2023)
-
Figure China Galectin 3 Production Volume and Growth Rate of KTI (2018-2023)
-
Figure China Galectin 3 Production Volume and Growth Rate of Others (2018-2023)
-
Figure China Galectin 3 Market Share by Application in 2018
-
Figure China Galectin 3 Market Share by Application in 2023
-
Figure China Galectin 3 Total Market Size and Growth Rate from Consumption End
-
Figure China Galectin 3 Market Size and Growth Rate of Metastatic Melanoma (2018-2023)
-
Figure China Galectin 3 Market Size and Growth Rate of Others (2018-2023)
-
Figure China Galectin 3 Market Size and Growth Rate of Portal Hypertension (2018-2023)
-
Figure China Galectin 3 Market Size and Growth Rate of Liver Cirrhosis (2018-2023)
-
Table China Galectin 3 Production Volume by Region (2018-2023)
-
Table China Galectin 3 Production Volume Share by Region (2018-2023)
-
Figure China Galectin 3 Production Volume Share by Region (2018-2023)
-
Table China Galectin 3 Production Value by Region (2018-2023)
-
Table China Galectin 3 Production Value Share by Region (2018-2023)
-
Figure China Galectin 3 Production Value Share by Region (2018-2023)
-
Table China Galectin 3 Sales Volume by Region (2018-2023)
-
Table China Galectin 3 Sales Volume Share by Region (2018-2023)
-
Figure China Galectin 3 Sales Volume Share by Region (2018-2023)
-
Table China Galectin 3 Sales Value by Region (2018-2023)
-
Table China Galectin 3 Sales Value Share by Region (2018-2023)
-
Figure China Galectin 3 Sales Value Share by Region (2018-2023)
-
Table North China Galectin 3 Production Volume by Type (2018-2023)
-
Table North China Galectin 3 Production Volume Share by Type (2018-2023)
-
Figure North China Galectin 3 Production Volume Share by Type (2018-2023)
-
Table North China Galectin 3 Sales Volume by Application (2018-2023)
-
Table North China Galectin 3 Sales Volume Share by Application (2018-2023)
-
Figure North China Galectin 3 Sales Volume Share by Application (2018-2023)
-
Table Central China Galectin 3 Production Volume by Type (2018-2023)
-
Table Central China Galectin 3 Production Volume Share by Type (2018-2023)
-
Figure Central China Galectin 3 Production Volume Share by Type (2018-2023)
-
Table Central China Galectin 3 Sales Volume by Application (2018-2023)
-
Table Central China Galectin 3 Sales Volume Share by Application (2018-2023)
-
Figure Central China Galectin 3 Sales Volume Share by Application (2018-2023)
-
Table South China Galectin 3 Production Volume by Type (2018-2023)
-
Table South China Galectin 3 Production Volume Share by Type (2018-2023)
-
Figure South China Galectin 3 Production Volume Share by Type (2018-2023)
-
Table South China Galectin 3 Sales Volume by Application (2018-2023)
-
Table South China Galectin 3 Sales Volume Share by Application (2018-2023)
-
Figure South China Galectin 3 Sales Volume Share by Application (2018-2023)
-
Table East China Galectin 3 Production Volume by Type (2018-2023)
-
Table East China Galectin 3 Production Volume Share by Type (2018-2023)
-
Figure East China Galectin 3 Production Volume Share by Type (2018-2023)
-
Table East China Galectin 3 Sales Volume by Application (2018-2023)
-
Table East China Galectin 3 Sales Volume Share by Application (2018-2023)
-
Figure East China Galectin 3 Sales Volume Share by Application (2018-2023)
-
Table Northeast China Galectin 3 Production Volume by Type (2018-2023)
-
Table Northeast China Galectin 3 Production Volume Share by Type (2018-2023)
-
Figure Northeast China Galectin 3 Production Volume Share by Type (2018-2023)
-
Table Northeast China Galectin 3 Sales Volume by Application (2018-2023)
-
Table Northeast China Galectin 3 Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Galectin 3 Sales Volume Share by Application (2018-2023)
-
Table Southwest China Galectin 3 Production Volume by Type (2018-2023)
-
Table Southwest China Galectin 3 Production Volume Share by Type (2018-2023)
-
Figure Southwest China Galectin 3 Production Volume Share by Type (2018-2023)
-
Table Southwest China Galectin 3 Sales Volume by Application (2018-2023)
-
Table Southwest China Galectin 3 Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Galectin 3 Sales Volume Share by Application (2018-2023)
-
Table Northwest China Galectin 3 Production Volume by Type (2018-2023)
-
Table Northwest China Galectin 3 Production Volume Share by Type (2018-2023)
-
Figure Northwest China Galectin 3 Production Volume Share by Type (2018-2023)
-
Table Northwest China Galectin 3 Sales Volume by Application (2018-2023)
-
Table Northwest China Galectin 3 Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Galectin 3 Sales Volume Share by Application (2018-2023)
-
Table Galectin Therapeutics Inc Company Profile
-
Table Galectin Therapeutics Inc Galectin 3 Revenue, Price and Gross (2018-2023)
-
Table Angion Biomedica Corp Company Profile
-
Table Angion Biomedica Corp Galectin 3 Revenue, Price and Gross (2018-2023)
-
Table GlycoMimetics Inc Company Profile
-
Table GlycoMimetics Inc Galectin 3 Revenue, Price and Gross (2018-2023)
-
Table Bristol-Myers Squibb Company Company Profile
-
Table Bristol-Myers Squibb Company Galectin 3 Revenue, Price and Gross (2018-2023)
-
Table MandalMed Inc Company Profile
-
Table MandalMed Inc Galectin 3 Revenue, Price and Gross (2018-2023)
-
